Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.51 |
| ▸ | TP53 | P04637 | 4/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | HTR1A | P08908 | 6/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4729065 | 0.74 | MAPT (0.58) | MAPTTP53LMNAHTR1ATHRB | |
| SCHEMBL8915792 | 0.74 | MAPT (0.58) | MAPTTP53LMNAHTR1ATHRB | |
| Hydrochloric Acid SCHEMBL4727330 | 0.73 | MAPT (0.57) | MAPTTP53LMNAHTR1ATHRB | |
| SCHEMBL6596271 | 0.69 | HTR1A (0.67) | HTR1A | |
| SCHEMBL7982396 | 0.69 | HTR1A (0.81) | HTR1A | |
| Hydrochloric Acid SCHEMBL7985771 | 0.69 | HTR1A (0.80) | HTR1A | |
| SCHEMBL13898747 | 0.66 | DRD4 (0.47) | MAPTTP53LMNATHRB | |
| SCHEMBL14493421 | 0.65 | DRD4 (0.49) | MAPT | |
| SCHEMBL2966951 | 0.63 | MAPT (0.48) | MAPTTP53LMNAHTR1ATHRB | |
| SCHEMBL8653538 | 0.63 | MAPT (0.48) | MAPTTP53LMNATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1337528-A2 | BENZOTHIOPHENE DERIVATIVE COMPOUNDS, PROCESS OF PREPARATION AND USE THEREOF | LABORATORIOS VITA, S.A. (ES) | 2003-08-27 | — | — | EP | disclosed |
| WO-2002044170-A2 | BENZOTHIOPHENE DERIVATIVE COMPOUNDS, PROCESS OF PREPARATION AND USE THEREOF | LABORATORIOS VITA, S.A. (ES) | 2002-06-06 | — | — | WO | disclosed |